MalarVx, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-08-258/25/26 | New | $125,000 | $125,000 | Other | 06b | SEC linkSEC |
| 2017-06-216/21/17 | Amended | $1,050,000 | $940,000 | Equity Only | 06b | SEC linkSEC |
| 2015-11-2311/23/15 | New | Yet to Sell | $0 | Equity Only | 06b | SEC linkSEC |
| 2015-01-301/30/15 | Amended | $110,000 | $0 | Equity Only | 06b | SEC linkSEC |
| 2015-01-201/20/15 | New | $110,000 | $110,000 | Equity Only | 04 | SEC linkSEC |
| 2012-10-1810/18/12 | New | Yet to Sell | $0 | Equity Only | 04.1 04.2 | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| James N/A Davie | Director |
| Jodi N/A Herczeg | Executive |
Industry: Biotechnology (See others in industry)
Address:
1551 Eastlake Ave E Suite 100
Seattle, WA, 98102
Phone: (646) 522-2458
Seattle, WA, 98102
Phone: (646) 522-2458